Whether they call it investigator or site relationship management, it seems that big pharma thinks it's just plain old good business. Something they openly admit they hadn't been focused on.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content